Study on the influence of Topiroxostat on renal function
Phase of Trial: Phase IV
Latest Information Update: 01 Aug 2019
Price : $35 *
At a glance
- Drugs Topiroxostat (Primary)
- Indications Hyperuricaemia
- Focus Therapeutic Use
- 28 Feb 2019 Status changed from active, no longer recruiting to completed.
- 26 Dec 2018 Status changed from not yet recruiting to active, no longer recruiting.
- 28 Sep 2018 New trial record